Patent portfolio with over 100 patents, issued and pending, protects technology targeting a $100 billion market opportunity
Company developing potential breakthrough two-fold technology that can...
PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today...
In a recent review published in the journal Antioxidants, researchers explored the potential of nano-formulations to boost the bioavailability and bioactivity of curcumin and...
Post-meal hyperglycemia was significantly reduced by 20% with inhaled insulin compared with rapid-acting insulin delivered through MDI or insulin pumps
Subjects utilizing inhaled insulin experienced...
Appointment effective February 12 following Nadim Yared’s retirement
Hykes currently serves as Augmedics’ President and CEO, and has served on CVRx’s Board of Directors...
Klotter, V. et al. Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: results from a prospective longitudinal cohort study. PLoS...
PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION23 January 2024, 07:00 am CET
DSMBi rates DSR 2.0 as safe following review of data from non-randomized cohort
Data from...
You’ve heard about poker individuals winning thousands and thousands of funds both online and in offIine events such as the Universe Range of Poker....
– Achieved Full Year 2023 Preliminary Global Net Product Revenues of $1,241 Million for ONPATTRO®, AMVUTTRA®, GIVLAARI®, and OXLUMO®, Representing 39% Annual Growth (39%...
